D-0626-2026 Class II Ongoing

Recalled by Annora Pharma Private Limited — Hyderabad, N/A

FDA drug recall D-0626-2026 was initiated by Annora Pharma Private Limited on Jun 4, 2026 and is designated Class II. Reason for recall: Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg. The recall status is ongoing. Affected quantity: 31,392 60-count bottles.

Recall details

Product Type
Drugs
Report Date
Jul 1, 2026
Initiation Date
Jun 4, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
31,392 60-count bottles

Product description

Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.

Reason for recall

Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.

Distribution pattern

Nationwide in the USA

Code information

Lot: A253999, A254000, Expires: 09/30/2027.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0626-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0626-2026. Report a data issue: hello@regdatalab.com.